Clinical trials
Neoplasms clinical trials
Below are recruiting neoplasms clinical trials, each written for real people, not researchers. We’re tracking 1,642 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05851547RecruitingPhase 2
Testing higher doses in prostate spots using MRI guidance
This Phase 2 trial studies a way to deliver higher radiation doses to specific prostate lesions seen on a 3-Tesla MRI. It’s for people with certain intermediate- or high-risk prostate cancer to see if targeting the lesions can improve treatment results and safety.
Ottawa, OntarioAges 18 years+ - NCT07863466Recruiting
Tracking outcomes for chronic blood cancers
This study follows people with certain chronic blood cancers to understand how the diseases progress and how treatments affect outcomes over time. It may help improve care for future patients.
MilanAges 16 years+ - NCT02925234RecruitingPhase 2
Basket trial of reused cancer drugs matched to tumor markers
This trial tests cancer drugs that are already approved for other cancers, chosen based on specific changes found in your tumor. It may help people whose cancer is growing despite standard treatment (or who no longer have standard options).
AlkmaarAges 18 years+ - NCT06234137Recruiting
Chemo plus targeted therapy for advanced HER2+ breast cancer
This trial tests a combination of chemotherapy (docetaxel and carboplatin) plus two targeted drugs (Inetetamab and Pyrotinib) for people with locally advanced HER2-positive breast cancer that has not spread to other parts of the body. The goal is to see if this powerful combo can shrink the tumor before surgery or other treatments.
Wenzhou, ZhejiangAges 18–75 - NCT06226857RecruitingPhase 3
Anti-EGFR for left-sided, RAS wild-type metastatic colorectal cancer
This trial tests whether anti-EGFR therapy works better for people with left-sided colorectal cancer that has spread, whose tumors do not have certain gene mutations (RAS wild-type). It is for those who have not yet had treatment for metastatic disease.
MoscowAges 18–99 - NCT06236789Recruiting
Ifosfamide for men with advanced prostate cancer
This trial is studying whether the chemotherapy drug ifosfamide (given with mesna to protect the bladder) can help men whose prostate cancer has spread and is no longer controlled by hormone therapy. It is for men who have already tried the chemotherapy docetaxel.
SeoulAges 19 years+ - NCT06235931Recruiting
Darcilil with AI and pyrrotinib for advanced breast cancer
This trial tests a combination of three drugs (darcilil, an aromatase inhibitor, and pyrrotinib) for older adults with a specific type of advanced breast cancer that has both HER2 and hormone receptors. It aims to see if this mix works better than current treatments.
Suzhou, JiangsuAges 65 years+ - NCT05753826RecruitingPhase 2
Study of two medicines for platinum-resistant ovarian cancer
This Phase 2 trial studies whether adding adebrelimab to fuzuloparib can help people with ovarian cancer that comes back quickly after platinum chemotherapy. It is aimed especially at tumors with a specific DNA-repair gene (HRR mutation).
FujianAges 18–70 - NCT06250595Recruiting
European rare blood disorder registry
This study is building a registry of people with rare blood diseases. By joining, you help doctors learn more about these conditions and improve future care.
Barcelona, CataloniaAges Up to 100 years - NCT03222895Recruiting
Mapping lymph node spread in resectable esophageal cancer
This study looks at how esophageal (or esophagus-stomach junction) cancer spreads to nearby lymph nodes. Results may help doctors understand where cancer cells are likely to be, potentially improving future surgery planning.
Houston, TexasAges 18 years+ - NCT06259513Recruiting
Skipping armpit surgery for breast cancer patients
This trial tests whether it's safe to skip armpit surgery in older women with small, low-risk breast cancers. If you qualify, you would have a mastectomy without removing lymph nodes from your armpit.
SingaporeAges 21–80 - NCT03326947RecruitingPhase 2
Stathmin test to guide chemotherapy for oral cancer
This Phase 2 trial uses a lab test called “Stathmin” to help predict who may benefit from a specific chemotherapy plan for squamous cell carcinoma of the mouth. It aims to improve treatment choice by linking Stathmin levels to how well chemotherapy works.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06223295Recruiting
Focal therapy for medium-risk prostate cancer
This trial tests a gentler treatment called focal therapy that targets only the part of the prostate with cancer. It's for men whose prostate cancer has a Gleason score of 7, low PSA, and hasn't spread outside the prostate.
Nijmegen, GelderlandAges 45 years+ - NCT04810871Recruiting
Surgery for brain tumors that may come back
This study tests whether removing a brain tumor early, before it shows signs of growing back, can help prevent a recurrence. If you have had treatment before and there is still some tumor left, you may be able to join.
Rochester, MinnesotaAges 18 years+ - NCT07859488Recruiting
Delirium risk after cancer surgery
After surgery for cancer in the belly area, some older adults become confused or have memory problems. This study looks for early signs in the blood that might predict this, so doctors can help prevent it.
Istanbul, IstanbulAges 65 years+ - NCT07874308Recruiting
Preventing nausea and vomiting from chemotherapy
This study tests a new anti-nausea drug (HR20013) in patients receiving chemotherapy that often causes nausea and vomiting. It aims to see how well it works in real-world conditions, including for patients with liver problems.
Guangzhou, GuangdongAges 18 years+ - NCT06291610Recruiting
Testing a decision-support tool for cancer trial choices
This study tests a tool to help patients with throat or voice box cancer decide whether to join a larger trial. It aims to make the decision process clearer and less overwhelming.
AarhusAges 18 years+ - NCT06313463RecruitingPhase 3
Capecitabine and camrelizumab for TNBC after chemotherapy
This trial tests if combining the chemotherapy pill capecitabine with the immunotherapy drug camrelizumab can help people with triple-negative breast cancer (TNBC) who still have tumor tissue after initial treatment. It is for patients whose breast cancer has structures called tumor-associated lymphoid structures (TLS) and who did not achieve a complete response to neoadjuvant therapy.
Guangzhou, GuangdongAges 18–80 - NCT06319157Recruiting
Minimal access vs. standard back muscle flap for breast reconstruction
This study compares a less invasive method of harvesting the latissimus dorsi (a back muscle) for breast reconstruction. It is for early-stage breast cancer patients who have mild to moderate breast sagging and want to use their own tissue for reconstruction.
Guangzhou, GuangdongAges 18–70 - NCT05217407Recruiting
Registry study for people with rare or advanced cancers
This is a study that collects information about people with rare cancers (or cancers where the source is unknown) and advanced-stage cancer. It helps researchers build a knowledge database to improve understanding and care for these cancers in Asia.
Chuo-ku, TokyoAges 18 years+ - NCT03973671Recruiting
Collecting blood and tissue samples during bladder cancer surgery
This study collects clinical and tissue samples from people who are having surgery for bladder cancer and related urinary-tract tumors. It aims to improve understanding of cancer and may help future care by building a large research dataset.
Leuven, Vlaams-BrabantAges 18–90 - NCT06337760Recruiting
Young Adults with Digestive and Neuroendocrine Cancers
This trial studies treatments for young adults (ages 18-39) with cancers of the digestive system or neuroendocrine tumors. It aims to find better ways to help this age group, no matter the cancer stage or grade.
MilanAges 18–39 - NCT06338332Recruiting
Stent before surgery for right-sided colon blockage from cancer
This trial tests whether placing a stent first to relieve a blockage in the right side of the colon improves outcomes before surgery for colon cancer. It aims to help patients who come to the hospital with a blocked colon due to cancer.
Breda, North BrabantAges 18 years+ - NCT04603209Recruiting
Check-in registry for radiation during breast-conserving surgery
This registry study tracks people with early-stage, single-area breast cancer to understand outcomes when radiation is given during breast-conserving surgery. It may help doctors improve treatment planning for patients like you.
Santa Monica, CaliforniaAges 18 years+
Hear when a new Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neoplasms?
- Yes. Clin2 currently lists 1,642 recruiting neoplasms studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neoplasms trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neoplasms trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.